FDA Approved: VERQUVO — Supplemental Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

FDA approved a supplemental application for Verquvo (vericiguat) from Merck Sharp & Dohme LLC to modify the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Verquvo (vericiguat)

Snippet

SUPPL AP for VERQUVO (VERICIGUAT)